Statistics for Avadel Pharmaceuticals PLC (id:6508 AVDL)

Valuation metrics

Market cap

1.05B

Enterprise value

1.02B

Trailing P/E (ttm)

-5.38

Forward P/E

16.04

PEG ratio

16.04

Price/Sales (ttm)

7.61

Price/Book (mrq)

14.08

Enterprise Value/Revenue

7.41

Enterprise Value/EBITDA

-16.51

Overview

Shares outstanding

96.36M

Float

83.31M

Shares short

9.45M

% Held by insiders

0.05%

% Held by institutions

0.80%

Average volume (10 days)

2.04M

Average volume (90 days)

Price summary

52-Week low

10.41

52-Week high

19.09

52-Week change

-6.33%

Beta

50-Day moving average

13.49

200-Day moving average

15.23

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-52.53%

Operating margin

-0.65%

Operational effectiveness

Return on assets

-22.14%

Return on equity

-78.54%

Income statement

Revenue (ttm)

1.48

Revenue per share (ttm)

1.48

Quarterly revenue growth (yoy)

Gross profit (ttm)

27.12M

EBITDA

-62,007,000.00

Net income to common (ttm)

-72,575,000.00

Diluted EPS (ttm)

-0.75

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

65.81M

Total cash per share (mrq)

0.68

Total debt (mrq)

38.25M

Total Debt/Equity (mrq)

51.24

Current ratio (mrq)

297.40%

Book value per share (mrq)

0.78

Cash flow

Cash flow statement

-82,809,000.00

Levered free cash flow (LFCF)

-58,922,500.00